Ordinal Score Predicts Freedom From Epilepsy One Year After Surgery
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 5, 2024 -- An ordinal score incorporating eight independent binary clinical variables shows good performance for predicting seizure freedom one year after surgery for mesial temporal lobe epilepsy, according to a study published in the September issue of the Annals of Clinical and Translational Neurology.
Adam S. Dickey, M.D., Ph.D., from Emory University in Atlanta, and colleagues predicted one-year seizure freedom using a combination of eight relevant clinical variables. The analysis included 101 patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy.
The researchers found that significant predictors for seizure freedom were evidence of mesial temporal sclerosis and unitemporal interictal discharges in a univariate analysis. The ordinal SCORE model, built using a 0- to 8-point ordinal score awarding 1 point for each binary predictor, had a significantly higher area under the curve (AUC, 0.70) than the other three models: mesial temporal sclerosis (AUC, 0.54), FULL, using all eight binary predictors (AUC, 0.62), or Akaike information criteria, using backwards selection of variables (AUC, 0.53).
"Our overall conclusion is that the concordance of multiple clinical datapoints better predicts seizure freedom after SLAH than any one datapoint alone," the authors write. "Future research will incorporate additional data -- such as semiology and neuropsychological profile -- into the ordinal score described here."
Several authors disclosed ties to Medtronic, and SLAH was performed using a Medtronic laser ablation system.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Tumor-Related Epilepsy Not Strong Prognostic Factor in Diffuse Glioma
WEDNESDAY, May 21, 2025 -- For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study published in the May issue of...
All-Cause Mortality Higher With Sleep Deprivation in Seniors With Epilepsy
MONDAY, May 19, 2025 -- Older adults with sleep deprivation and epilepsy have an elevated risk for all-cause mortality, according to a study published online April 23 in...
New Definition of Epilepsy Improves Diagnosis, Treatment
TUESDAY, April 15, 2025 -- The new International League Against Epilepsy (ILAE) definition of epilepsy results in a higher frequency of epilepsy diagnosis and treatment, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.